UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1413) 1413
life sciences & biomedicine (1370) 1370
animals (1103) 1103
humans (796) 796
neurosciences & neurology (761) 761
male (747) 747
hypoxia-ischemia, brain - drug therapy (716) 716
neurosciences (666) 666
rats (664) 664
female (624) 624
animals, newborn (577) 577
infant, newborn (461) 461
hypoxia-ischemia, brain - pathology (429) 429
hypoxia-ischemia, brain - metabolism (427) 427
hypoxia-ischemia, brain - physiopathology (425) 425
disease models, animal (414) 414
brain (375) 375
ischemia (364) 364
pediatrics (355) 355
rats, sprague-dawley (340) 340
neuroprotective agents - pharmacology (329) 329
hypoxia-ischemia, brain - therapy (325) 325
neuroprotection (322) 322
hypoxia (313) 313
neurology (284) 284
neuroprotective agents - therapeutic use (274) 274
infants (256) 256
hypoxia-ischemia (247) 247
hypoxia-ischemia, brain - complications (246) 246
clinical neurology (241) 241
brain - drug effects (239) 239
brain - pathology (231) 231
rats, wistar (231) 231
injuries (228) 228
treatment outcome (220) 220
hypothermia (210) 210
apoptosis (208) 208
brain damage (194) 194
encephalopathy (192) 192
brain - metabolism (189) 189
time factors (184) 184
neurons - drug effects (179) 179
brain injury (169) 169
mice (168) 168
hypoxia-ischemia, brain - prevention & control (161) 161
apoptosis - drug effects (160) 160
hypoxia-ischemia, brain - etiology (155) 155
neonates (148) 148
hypothermia, induced (146) 146
analysis (141) 141
health aspects (138) 138
neurons (137) 137
brain - physiopathology (136) 136
pregnancy (130) 130
neurons - metabolism (126) 126
stroke (122) 122
hypothermia, induced - methods (121) 121
abridged index medicus (119) 119
dose-response relationship, drug (119) 119
electroencephalography (118) 118
rodents (118) 118
care and treatment (110) 110
hypoxia-ischemia, brain - diagnosis (110) 110
inflammation (103) 103
cell biology (100) 100
hypoxic-ischemic encephalopathy (98) 98
infant (98) 98
magnetic resonance imaging (98) 98
neurons - pathology (98) 98
research (97) 97
cells, cultured (96) 96
traumatic brain injury (93) 93
biochemistry & molecular biology (91) 91
neuroprotective agents - administration & dosage (89) 89
oxidative stress (86) 86
pharmacology & pharmacy (86) 86
hippocampus - drug effects (85) 85
cell death (82) 82
immunohistochemistry (78) 78
prognosis (78) 78
seizures (78) 78
asphyxia (77) 77
developmental biology (74) 74
newborn (74) 74
retrospective studies (73) 73
mice, inbred c57bl (72) 72
biomedicine (71) 71
hypoxia–ischemia (71) 71
random allocation (71) 71
general & internal medicine (70) 70
adult (69) 69
obstetrics & gynecology (69) 69
oxidative stress - drug effects (69) 69
middle aged (68) 68
hippocampus - pathology (66) 66
apoptosis - physiology (65) 65
maze learning - drug effects (65) 65
risk factors (65) 65
asphyxia neonatorum - complications (64) 64
cerebral ischemia (64) 64
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1658) 1658
Chinese (45) 45
Russian (26) 26
Spanish (10) 10
Japanese (4) 4
Norwegian (4) 4
Portuguese (3) 3
Danish (2) 2
Bulgarian (1) 1
Dutch (1) 1
German (1) 1
Polish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature neuroscience, ISSN 1097-6256, 08/2011, Volume 14, Issue 8, pp. 1009 - 1016
Permanent damage to white matter tracts, comprising axons and myelinating oligodendrocytes, is an important component of brain injuries of the newborn that cause cerebral palsy and cognitive... 
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Ki-67 Antigen - metabolism | Male | Brain Injuries - metabolism | Wnt Proteins - metabolism | Oligodendroglia - drug effects | Hypoxia-Ischemia, Brain - therapy | Infant, Newborn | Organ Culture Techniques | Disease Models, Animal | Animals, Newborn | Basic Helix-Loop-Helix Transcription Factors - genetics | Mice, Transgenic | Oligodendrocyte Transcription Factor 2 | Brain Injuries - therapy | Multiple Sclerosis - therapy | Myelin Proteins - genetics | beta Catenin - metabolism | Heterocyclic Compounds, 3-Ring - therapeutic use | Spinal Cord - physiology | Axin Protein | Mice | Myelin Sheath - ultrastructure | beta-Galactosidase - genetics | Cerebellum - ultrastructure | Myelin Proteins - metabolism | Corpus Callosum - metabolism | Spinal Cord - drug effects | Heterocyclic Compounds, 3-Ring - pharmacology | Myelin Proteins - therapeutic use | Cerebellum - drug effects | Myelin Sheath - drug effects | Hypoxia-Ischemia, Brain - pathology | Cerebral Cortex - cytology | Cytoskeletal Proteins - deficiency | Dose-Response Relationship, Drug | Oligodendroglia - physiology | Wnt Proteins - genetics | beta-Galactosidase - metabolism | Adult | Cytoskeletal Proteins - metabolism | Female | Demyelinating Diseases - chemically induced | Demyelinating Diseases - pathology | Neurons - drug effects | Cell Differentiation - physiology | Hypoxia-Ischemia, Brain - metabolism | Microscopy, Electron, Transmission | Myelin Sheath - pathology | Gene Expression Regulation - genetics | Cerebellum - metabolism | Cells, Cultured | Gene Expression Regulation - physiology | Corpus Callosum - drug effects | Nerve Tissue Proteins - genetics | beta Catenin - genetics | Multiple Sclerosis - complications | Nerve Tissue Proteins - metabolism | Animals | Cell Differentiation - drug effects | Multiple Sclerosis - pathology | Stem Cells - drug effects | Brain Injuries - etiology | Lysophosphatidylcholines - toxicity | Postmortem Changes | Infants (Newborn) | Brain | Care and treatment | Physiological aspects | Research | Binding proteins | Health aspects | Injuries | Index Medicus
Journal Article
Pediatrics (Evanston), ISSN 1098-4275, 07/2009, Volume 124, Issue 2, pp. e218 - e226
OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of erythropoietin in neonatal hypoxic-ischemic encephalopathy (HIE), by using a... 
Neonates | Asphyxia | Erythropoietin | Hypoxic-ischemic encephalopathy | Life Sciences & Biomedicine | Pediatrics | Science & Technology | Brain Damage, Chronic - diagnosis | Prospective Studies | Follow-Up Studies | Humans | Developmental Disabilities - prevention & control | Erythropoietin - adverse effects | Infant | Male | Recombinant Proteins | Asphyxia Neonatorum - drug therapy | Dose-Response Relationship, Drug | Intensive Care Units, Neonatal | Asphyxia Neonatorum - diagnosis | China | Injections, Subcutaneous | Female | Developmental Disabilities - diagnosis | Psychomotor Disorders - prevention & control | Infant, Newborn | Disability Evaluation | Erythropoietin - administration & dosage | Drug Administration Schedule | Hypoxia-Ischemia, Brain - drug therapy | Hypoxia-Ischemia, Brain - diagnosis | Psychomotor Disorders - diagnosis | Neurologic Examination - drug effects | Infusions, Intravenous | Brain Damage, Chronic - prevention & control | Babies | Developmental psychology | Clinical trials | Glycoproteins | Drug therapy | Drug dosages | Clinical outcomes | Effectiveness studies | Index Medicus | Abridged Index Medicus | Developmental Disabilities | Hypoxia-Ischemia | Brain | Neonatal | MEDICIN OCH HÄLSOVETENSKAP | administration & dosage | Asphyxia Neonatorum | MEDICAL AND HEALTH SCIENCES | Recombinant | Drug | Intensive Care Units | drug therapy | Intravenous | Subcutaneous | Infusions | diagnosis | drug effects | prevention & control | Chronic | Injections | Newborn | Neurologic Examination | adverse effects | Dose-Response Relationship | Brain Damage | Psychomotor Disorders
Journal Article
Neurobiology of disease, ISSN 0969-9961, 03/2010, Volume 37, Issue 3, pp. 711 - 722
.... This study investigates whether EP can protect against neonatal hypoxic-ischemic (H-I) brain injury. Pre-treatment with EP significantly reduced brain damage at 7 days post-H-I, with 50 mg/kg EP achieving over 50... 
Neurology | Neuroprotection | NF-κB | Neonatal hypoxia-ischemia | Calcium | Cell death | Calpain | Inflammation | Microglia | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Encephalitis - prevention & control | Neuroprotective Agents - therapeutic use | Asphyxia Neonatorum - physiopathology | Neurons - pathology | Calpain - metabolism | Pyruvates - pharmacology | Calcium Signaling - physiology | Humans | Nerve Degeneration - physiopathology | NF-kappa B - metabolism | Cytoprotection - physiology | Asphyxia Neonatorum - drug therapy | Brain - metabolism | Encephalitis - physiopathology | Microglia - physiology | Neuroprotective Agents - pharmacology | Pyruvates - therapeutic use | Encephalitis - drug therapy | Nerve Degeneration - prevention & control | Cytoprotection - drug effects | Inflammation Mediators - antagonists & inhibitors | Neurons - metabolism | Cell Death - drug effects | Neurons - drug effects | Hypoxia-Ischemia, Brain - metabolism | Infant, Newborn | Disease Models, Animal | Animals, Newborn | NF-kappa B - antagonists & inhibitors | Asphyxia Neonatorum - metabolism | Microglia - drug effects | Brain - physiopathology | Hypoxia-Ischemia, Brain - drug therapy | Rats | Treatment Outcome | Rats, Sprague-Dawley | Brain - drug effects | Animals | Cell Death - physiology | Signal Transduction - drug effects | Calcium Signaling - drug effects | Signal Transduction - physiology | Calpain - antagonists & inhibitors | Nerve Degeneration - drug therapy | Hypoxia-Ischemia, Brain - physiopathology | Brain | Anti-inflammatory drugs | Neurons | Analysis | Brain damage | Injuries | Index Medicus | calpain | calcium | cell death | inflammation | neuroprotection | neonatal hypoxia-ischemia | microglia
Journal Article
Molecular brain, ISSN 1756-6606, 2015, Volume 8, Issue 1, pp. 11 - 11
Background: Our previous study found that suppression of TRPM7 reduced neuronal death in adult rat ischemic brain injury... 
Neuroprotection | Carvacrol | TRPM7 | Neonatal hypoxic-ischemic brain injury | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroprotective Agents - therapeutic use | Neurons - pathology | Apoptosis - drug effects | Humans | Caspase 3 - metabolism | Brain Infarction - pathology | Glucose | Hippocampus - drug effects | Hypoxia-Ischemia, Brain - pathology | Neuroprotection - drug effects | Monoterpenes - pharmacology | Brain Infarction - complications | Neuroprotective Agents - pharmacology | HEK293 Cells | Behavior, Animal - drug effects | Neurons - metabolism | Phosphorylation - drug effects | Neurons - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Monoterpenes - therapeutic use | Animals, Newborn | Oxygen | Brain - physiopathology | Hypoxia-Ischemia, Brain - drug therapy | bcl-2-Associated X Protein - metabolism | Rats | Hippocampus - pathology | Brain Infarction - physiopathology | Hypoxia-Ischemia, Brain - complications | Brain - drug effects | Animals | TRPM Cation Channels - antagonists & inhibitors | Brain - pathology | Mice | TRPM Cation Channels - metabolism | Hippocampus - physiopathology | Hypoxia-Ischemia, Brain - physiopathology | Ion Channel Gating - drug effects | Infants (Newborn) | Stroke (Disease) | Brain | Ischemia | Neurons | Research | Instrument industry | Injuries | Index Medicus
Journal Article
Journal Article
CNS neuroscience & therapeutics, ISSN 1755-5930, 05/2017, Volume 23, Issue 5, pp. 405 - 415
Journal Article
Stroke (1970), ISSN 0039-2499, 09/2010, Volume 41, Issue 9, pp. 2050 - 2055
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1524-4636, 02/2014, Volume 34, Issue 2, pp. 285 - 293
...–coupled receptor (GPR) 91. We postulate that succinate/GPR91 enhances post-HI vascularization and reduces infarct size in a model of newborn HI brain injury... 
animals newborn | succinic acid | GPR91 protein mouse | hypoxia-ischemia brain | intracellular signaling peptides and proteins | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Receptors, G-Protein-Coupled - metabolism | Succinic Acid - administration & dosage | Astrocytes - pathology | Cerebral Cortex - pathology | Injections, Intraventricular | Neuroprotective Agents - metabolism | Hypoxia-Ischemia, Brain - etiology | Cerebral Infarction - physiopathology | Neuroprotective Agents - pharmacology | Time Factors | Neurons - metabolism | Cerebral Cortex - drug effects | Disease Models, Animal | Animals, Newborn | Endothelial Cells - metabolism | Mice, Knockout | Dinoprostone - metabolism | Signal Transduction - drug effects | Succinic Acid - metabolism | Cerebral Infarction - etiology | Mice | Receptors, G-Protein-Coupled - genetics | Endothelial Cells - pathology | Angiogenic Proteins - metabolism | Astrocytes - metabolism | Cerebral Infarction - drug therapy | Neovascularization, Physiologic - drug effects | Neurons - pathology | Cerebral Cortex - blood supply | Hypoxia-Ischemia, Brain - pathology | Receptors, G-Protein-Coupled - agonists | Cerebral Infarction - genetics | Hypoxia-Ischemia, Brain - genetics | Cerebral Cortex - metabolism | Cerebral Infarction - metabolism | Prostaglandin Antagonists - pharmacology | Neurons - drug effects | Neuroprotective Agents - administration & dosage | Hypoxia-Ischemia, Brain - metabolism | Receptors, Prostaglandin E, EP4 Subtype - drug effects | Cerebral Infarction - pathology | Receptors, Prostaglandin E, EP4 Subtype - metabolism | Astrocytes - drug effects | Cell Line | Tissue Culture Techniques | Mice, Inbred C57BL